Glypican-3 antibody and uses thereof
US10093746B2 · kind B2 · utility
3Cited by
2References
23Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Sep 3, 2015 |
| Grant date | Oct 9, 2018 |
| Priority date | — |
| Expiry date | Oct 4, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods of isolated polynucleotides that encode or polypeptides comprising glypican-3 (GPC3). The invention also includes a chimeric antigen receptor (CAR) wherein the CAR is able to target GPC3. The invention further includes methods of treating a subject or diagnosing and treating diseases, disorders or conditions associated with dysregulated glypican-3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.